Cervical intraepithelial neoplasia (CIN), also known as cervical dysplasia, is the abnormal growth of cells (neoplasia) or lesions on your outer cervix lining (intraepithelial). CIN can be ...

Here are 5 important questions to ask if you’ve been told you have cervical dysplasia: ...

A new HPV vaccine induced regression of precancerous cervical lesions in 50% of patients and led to viral clearance in some ...

A retrospective review of comprehensive quality assurance databases of screening tests and cervical biopsy results from the Regional Laboratory of the Kaiser Permanente Northern California (KPNC ...

Human papillomavirus (HPV) vaccines are in wide use around the world owing to the widespread implementation of immunization programs for young girls before they become sexually active. The phase ...

Cervical dysplasia can range from mild to severe, depending on the appearance of the abnormal cells. Another term for cervical dysplasia is cervical intraepithelial neoplasia, or CIN. The exact cause ...

In those with grade 3 cervical intraepithelial neoplasia (CIN3), cells are already on the path toward malignancy. If left untreated, approximately one-third of these cases progress to cervical ...

The human papilloma virus (HPV) is the cause of almost all cervical cancer. Cancer of the cervix usually takes many years to develop. Before it does so, patients may typically exhibit intraepithelial ...

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive cervical intraepithelial neoplasia grade 3 (CIN3), according to results from ...

50% of patients with CIN3 had histopathological complete response; 63% had HPV16 clearance. (HealthDay News) — For patients with human papillomavirus (HPV) type 16 (HPV16)-positive cervical ...

Fifty percent of patients with CIN3 had histopathological complete response; 63% had HPV16 clearance. HealthDay News — For patients with human papillomavirus (HPV) type 16 (HPV16)-positive ...